Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Study of KHK7580 vs cinacalcet in secondary hyperparathyroidism on hemodialysis
jRCT2080222961Phase 3
- Sponsor
- Kyowa Kirin
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ASP7991 in secondary hyperparathyroidism (SHPT) (2 arms), sponsored by Kyowa Kirin.
02
Drugs
ASP7991
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on jRCT2080222961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222961.